3C9-19451-79546
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 209 / MD
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-31
-
2021-01-05
Dose 2 — Pfizer-BioNTech
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Exposure during pregnancy — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
- 2021-02-02
-
2021-02-11
Survey response — 35 day, dose 2MedDRA: Benign hydatidiform mole — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-11
Report sent to call center — 35 day, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-18
-
2021-04-06
Survey response — 3 month, dose 2MedDRA: Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-06
Report sent to call center — 3 month, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-08
- 2021-07-06
- 2022-01-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-11 | Unsuccessful | |
| 2021-04-06 | Unsuccessful |
Free text
Release 1
Systemic reaction (other): Pregnancy
Release 4
Symptoms: Molar pregnancy
Release 7
Symptoms: GTN
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Benign hydatidiform mole | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Exposure during pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release